October 20, 2017
Add to Twitter
English | عربي
European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe
Symtuza® is the only darunavir-based single-tablet regimen (STR) approved for the treatment of HIV-1 in the European Union